Phase I Study of Accelerated Hypofractionated Radiotherapy with Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer: CALGB 31102 (Alliance)

PURPOSE: Investigate the safety of accelerated hypofractionated radiotherapy (AHRT) with concurrent chemotherapy (CT) for inoperable stage III non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: The primary objectives were to define the maximally tolerable course of accelerated radiotherapy an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Radiat Oncol Biol Phys
Auteurs principaux: Urbanic, James J., Wang, Xiaofei, Bogart, Jeffrey A., Stinchcombe, Thomas E., Hodgson, Lydia, Schild, Steven E., Bazhenova, Lyudmila, Hahn, Olwen, Salgia, Ravi, Vokes, Everett E.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173195/
https://ncbi.nlm.nih.gov/pubmed/29487024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2018.01.046
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires